Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

ACADIA Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the following investor conferences:•The Piper Jaffray 26th Annual Healthcare Conference on Tuesday, December 2, 20…

Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ — Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today…

Sequenom Inc. Announces Participation At The 26th Annual Piper Jaffray Healthcare Conference

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ –Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the Company’s participation at the 2014 Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York, NY

Isis Pharmaceuticals, Inc. Initiates Phase 3 Study Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy

November 24, 2014 – 5:00 pm | Edit Post

CARLSBAD, Calif., Nov. 25, 2014 /PRNewswire/ — Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the initiation of a pivotal Phase 3 study evaluating ISIS-SMNRx in approximately 120 non-ambulatory children with spinal muscular atrophy (SMA). SMA is a severe and rare genetic neuromuscular disease…

Neurocrine Biosciences, Inc. To Present At The 2014 Deutsche Bank Biofest And The 26th Annual Piper Jaffray Healthcare Conference

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ –Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at two investor conferences next week.On December…

Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO, CA–(Marketwired – November 25, 2014) – Regen BioPharma Inc. (OTCBB: RGBP) announced today acquisition of patent application # US 13/652,395 with a priority date of November 2008 which covers a novel gene target essential for the survival of cancer stem cells. Inventors of the intellectual property…

Ignyta To Present At Upcoming Investor Conferences

November 24, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, announced today that its management will be making company presentations at the following investor conferences in December 2014: •The Piper Jaffray 26th Annual Healthcare Conference at the Palace Hotel in New York, NY on December 2, 2014 at 9:30 a.m. Eastern time (presentation by Jonathan…

Alphatec Spine To Present At Upcoming Investor Events In December 2014

November 24, 2014 – 5:00 pm | Edit Post

CARLSBAD, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company’s executives, Jim Corbett, President and Chief Executive Officer, and Mike O’Neill…

Alphatec Spine Announces Appointment Of To Its Board Of Directors

November 24, 2014 – 5:00 pm | Edit Post

CARLSBAD, Calif., Nov. 24, 2014 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that its board of directors has appointed Tom C. Davis as a member of the board of directors, effectively…

First Angioedema Treatment Center Opens at UC San Diego Health System

November 24, 2014 – 2:28 pm | Edit Post

UC San Diego Health System in partnership with the U.S. Hereditary Angioedema Association (HAEA), a non-profit patient advocacy organization, has opened the nation’s first dedicated center for diagnosing and treating diverse forms of swelling, known collectively as angioedema.